Dr. James C. Yao on Everolimus in Pancreatic Neuroendocrine Tumors
13 Pogledi
• 07/13/23
0
0
Ugraditi
administrator
Pretplatnici
James C. Yao, MD, discusses the administration of everolimus (Afinitor) for patients with pancreatic neuroendocrine tumors
For more resources and information regarding targeted therapies in cancer: http://targetedhc.com/
Prikaži više
Komentari na Facebooku
SORT BY-
Najbolji komentari
-
Najnoviji komentari